Difference between revisions of "Analytical methods - Gentamycin"
| Line 1: | Line 1: | ||
| − | < | + | <p>US EPA residu analytical methods (RAM): Analytical method for the determination of gentamicin in pears (1993)</p> |
| − | + | <p></p> | |
| − | US EPA residu analytical methods (RAM): Analytical method for the determination of gentamicin in pears (1993) | + | <p></p> |
| − | + | <p></p> | |
| − | + | <p></p> | |
| − | + | <p></p> | |
| − | + | <p></p> | |
| − | + | <p><em><u>Legislation :</u></em></p> | |
| − | + | <p></p> | |
| − | + | <p>There is increasing awareness of food safety by the consumer with respect to antimicrobial resistance due to the | |
| − | + | discovery of new resistant strains of bacteria and others that are becoming increasingly resistant over time. As | |
| − | + | a result there is increasing pressure on laboratories responsible for food safety to monitor the use of these | |
| − | + | drugs and ensure the safety of food for human consumption. Legislation regarding the control of antibiotic | |
| − | + | residues in live animals and animal products is given in Coun-cil Directive 96/23/EC. In the context of this | |
| − | + | directive, details for methods and their performance criteria are described in Commission Decision | |
| − | + | 2002/657/EC. Residues are divided into two groups A and B for the purposes of monitoring and defining the | |
| − | + | legislation relating to them.</p> | |
| − | + | <p></p> | |
| − | + | <p>Group A refers to substances having an anabolic effect and unauthorised substances while | |
| − | + | group B refers to veterinary drugs and contaminants. The aminoglycosides and macrolides are both | |
| − | There is increasing awareness of food safety by the consumer with respect to antimicrobial resistance due to the discovery of new resistant strains of bacteria and others that are becoming increasingly resistant over time. As a result there is increasing pressure on laboratories responsible for food safety to monitor the use of these drugs and ensure the safety of food for human consumption. Legislation regarding the control of | + | listed under group B1 (antibacterial substances). The various sub-divisions of these two groups are listed |
| − | + | in Council directive 96/23/EC. The EU Council regulation 2377/90 lays down the Community procedure | |
| − | + | for the establishment of maximum residue limits (MRLs) of veterinary medicinal products in foodstuffs of animal | |
| − | + | origin.</p> | |
| − | Group A | + | <p></p> |
| − | + | <p>Some aminoglycosides with established MRLs are shown in Table 1 and some aminoglycosides with provisional | |
| − | + | MRLs are shown in Table 2. EU Council regulation 2377/90 also dictates the analytical methods that can be used | |
| − | + | for confirmatory analysis and these are listed in Table 3.</p> | |
| − | Some aminoglycosides with established MRLs are shown in | + | <p></p> |
| − | + | <p>Table 1</p> | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | < | ||
| − | |||
| − | |||
| − | |||
| − | < | ||
| − | |||
| − | |||
| − | |||
| − | </ | ||
| − | < | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | </ | ||
{| | {| | ||
|width="20%"| '''Pharmacologically<br /> | |width="20%"| '''Pharmacologically<br /> | ||
| − | + | (actvie substances)''' | |
|width="20%"| '''Marker residue''' | |width="20%"| '''Marker residue''' | ||
|width="20%"| '''Animal species''' | |width="20%"| '''Animal species''' | ||
| Line 156: | Line 44: | ||
| Muscle | | Muscle | ||
|- | |- | ||
| − | | | + | | |
| − | | | + | |
| − | | | + | | |
| + | |||
| + | | | ||
| + | |||
| 50 | | 50 | ||
| Fat | | Fat | ||
|- | |- | ||
| − | | | + | | |
| − | | | + | |
| − | | | + | | |
| + | |||
| + | | | ||
| + | |||
| 200 | | 200 | ||
| Liver | | Liver | ||
|- | |- | ||
| − | | | + | | |
| − | | | + | |
| − | | | + | | |
| + | |||
| + | | | ||
| + | |||
| 750 | | 750 | ||
| Kidney | | Kidney | ||
|- | |- | ||
| − | | | + | | |
| − | | | + | |
| + | | | ||
| + | |||
| Bovine | | Bovine | ||
| 100 | | 100 | ||
| Milk | | Milk | ||
|} | |} | ||
| + | 2 | ||
| − | + | {| | |
| + | | Table 2 Suitable confirmatory methods for organic residues or contaminants [11] | ||
| + | | | ||
| − | < | + | |- |
| − | + | | Measuring technique | |
| − | + | | Compound group<br /> | |
| − | + | from 96/23/E | |
| − | + | |- | |
| + | | LC or GC with mass-spectrometric detection | ||
| + | | Groups A and B | ||
| + | |- | ||
| + | | LC or GC with IR spectrometric detection | ||
| + | | Groups A and B | ||
| + | |- | ||
| + | | LC-full-scan DAD | ||
| + | | Group B | ||
| + | |- | ||
| + | | LC-fluorescence | ||
| + | | Group B | ||
| + | |- | ||
| + | | 2-D TLC-full-scan UV/VIS | ||
| + | | Group B | ||
| + | |- | ||
| + | | GC-Electron capture detection | ||
| + | | Group B | ||
| + | |- | ||
| + | | LC-immunogram | ||
| + | | Group B | ||
| + | |- | ||
| + | | LC–UV/VIS (single wavelength) | ||
| + | | Group B | ||
| + | |- | ||
| + | | ''Key'': LC: liquid chromatography; GC: gas chromatography; IR: infrared spectrometry; DAD: diode array detection; TLC: thin layer chromatography; UV/VIS: ultraviolet/visible spectrophotometry; HPTLC: high-performance thin layer chromatography. | ||
| + | | | ||
| − | + | |} | |
| − | |||
| − | |||
| − | + | values (from | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | + | To ensure that aminoglycosides are used only in approved situations and to control their use in meat-producing animals, targeted samples are taken at the slaughterhouse and screened for the presence of residues. A positive screening result means that the sample must be subjected to confirmatory analysis. This assay must adhere to Commission Decision 2002/657/EC whereby suitable confirmatory methods are based on a required number of identification points. For the identity of group B compounds such as the aminoglycosides, a minimum of three identification points are required. As a consequence, methods that are based on chromatographic analysis followed by mass spectrometric detection are becoming the normal way of confirming identity and determining concentration. | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | + | '''''Other methods available''''' | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
'''''Alternative methods from literature''''' | '''''Alternative methods from literature''''' | ||
| − | '''esticides: Analyical ''' | + | '''esticides: Analyical''' |
Revision as of 14:27, 23 May 2017
US EPA residu analytical methods (RAM): Analytical method for the determination of gentamicin in pears (1993)
Legislation :
There is increasing awareness of food safety by the consumer with respect to antimicrobial resistance due to the discovery of new resistant strains of bacteria and others that are becoming increasingly resistant over time. As a result there is increasing pressure on laboratories responsible for food safety to monitor the use of these drugs and ensure the safety of food for human consumption. Legislation regarding the control of antibiotic residues in live animals and animal products is given in Coun-cil Directive 96/23/EC. In the context of this directive, details for methods and their performance criteria are described in Commission Decision 2002/657/EC. Residues are divided into two groups A and B for the purposes of monitoring and defining the legislation relating to them.
Group A refers to substances having an anabolic effect and unauthorised substances while group B refers to veterinary drugs and contaminants. The aminoglycosides and macrolides are both listed under group B1 (antibacterial substances). The various sub-divisions of these two groups are listed in Council directive 96/23/EC. The EU Council regulation 2377/90 lays down the Community procedure for the establishment of maximum residue limits (MRLs) of veterinary medicinal products in foodstuffs of animal origin.
Some aminoglycosides with established MRLs are shown in Table 1 and some aminoglycosides with provisional MRLs are shown in Table 2. EU Council regulation 2377/90 also dictates the analytical methods that can be used for confirmatory analysis and these are listed in Table 3.
Table 1
| Pharmacologically (actvie substances) |
Marker residue | Animal species | MRLs (µg kg−1 ) |
Target tissues |
| Gentamicin | Gentamicin | Bovine Porcine | 50 | Muscle |
| 50 | Fat | |||
| 200 | Liver | |||
| 750 | Kidney | |||
| Bovine | 100 | Milk |
2
| Table 2 Suitable confirmatory methods for organic residues or contaminants [11] | |
| Measuring technique | Compound group from 96/23/E |
| LC or GC with mass-spectrometric detection | Groups A and B |
| LC or GC with IR spectrometric detection | Groups A and B |
| LC-full-scan DAD | Group B |
| LC-fluorescence | Group B |
| 2-D TLC-full-scan UV/VIS | Group B |
| GC-Electron capture detection | Group B |
| LC-immunogram | Group B |
| LC–UV/VIS (single wavelength) | Group B |
| Key: LC: liquid chromatography; GC: gas chromatography; IR: infrared spectrometry; DAD: diode array detection; TLC: thin layer chromatography; UV/VIS: ultraviolet/visible spectrophotometry; HPTLC: high-performance thin layer chromatography. |
values (from
To ensure that aminoglycosides are used only in approved situations and to control their use in meat-producing animals, targeted samples are taken at the slaughterhouse and screened for the presence of residues. A positive screening result means that the sample must be subjected to confirmatory analysis. This assay must adhere to Commission Decision 2002/657/EC whereby suitable confirmatory methods are based on a required number of identification points. For the identity of group B compounds such as the aminoglycosides, a minimum of three identification points are required. As a consequence, methods that are based on chromatographic analysis followed by mass spectrometric detection are becoming the normal way of confirming identity and determining concentration.
Other methods available
Alternative methods from literature
esticides: Analyical